EN
HI
Alembic Pharmaceuticals share price chart
Alembic Pharmaceuticals Share Key Metrics
Volume
92763.00
Market Cap
16506.39 CR
LTQ@LTP
5@839.75
ATP
843.55
Var Margin
16.15 %
Circuit Range
680.05-1020.05
Delivery %
47.73 %
Value
7.83 CR
ASM/GSM
No
Market Lot
1
Summary
APLLTD stock price is ₹839.75 as of 16 Jul, 2026. The stock intraday movement has stayed between ₹837.10 and ₹855.40, while Alembic Pharmaceuticals share price 52 week high low is ₹635.80 & ₹1044.80.
In terms of trading activity, APLLTD share price has recorded a volume of 92,763 shares. The Alembic Pharmaceuticals has a market cap of ₹196563124. The stock’s Average Traded Price (ATP) stands at ₹843.55, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5 @ ₹839.75.
The Alembic Pharmaceuticals upper circuit limit is ₹1020.05 & The Alembic Pharmaceuticals lower circuit limit is ₹680.05, with a Value of ₹7.83 CR. The Delivery Percentage for the day is 47.73%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Alembic Pharmaceuticals Fundamentals
P/E Ratio
24.76
P/B Ratio
2.94
Div. Yield
1.41
Sector P/E
70.14
Sector P/B
3.3
Sec. Div. Yield
0.52
Alembic Pharmaceuticals Resistance and Support
Pivot 840.37
Resistance
First Resistance
863.64
Second Resistance
877.22
Third Resistance
900.49
Support
First Support
826.79
Second Support
803.52
Third Support
789.94
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Alembic Pharma received notification that the USFDA issued a Warning Letter to a clinical investigator linked to its Bioequivalence Facility. The letter addresses an Informed Consent Form observation, explicitly stating no data integrity issues or operational restrictions for the facility.
Jul 13 2026 18:40:37
Alembic Pharmaceuticals Ltd - 533573 - Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2026.
Alembic Pharmaceuticals has set July 29, 2026, as the Record Date for its equity dividend for FY26. Payment for the financial year ended March 31, 2026, will commence on or from August 6, 2026.
Jul 10 2026 16:53:27
Read More
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Onesource Specialty Pharma Ltd.
1649.20
9.20 (0.56%)
Astrazeneca Pharma India Ltd.
8086.00
-142.50 (1.73%)
Natco Pharma Ltd.
966.20
-3.55 (0.37%)
Cohance Lifesciences Ltd.
441.75
7.00 (1.61%)
Poly Medicure Ltd.
1722.70
7.10 (0.41%)
Dr. Agarwal's Health Care Ltd.
492.15
-1.60 (0.32%)
Jubilant Pharmova Ltd.
1020.70
-7.70 (0.75%)
Rainbow Children's Medicare Ltd.
1490.80
-10.80 (0.72%)
Vijaya Diagnostic Centre Ltd.
1412.50
23.10 (1.66%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 839.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 24.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.94. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 70.14 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 16506.39 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1044.80 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
